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Abstract
Objective: To examine the association between depression and all-cause and cardiovascular mortality in people with
diabetes by systematically reviewing the literature and carrying out a meta-analysis of relevant longitudinal studies.
Research Design and Methods: PUBMED and PSYCINFO were searched for articles assessing mortality risk associated with
depression in diabetes up until August 16, 2012. The pooled hazard ratios were calculated using random-effects models.
Results: Sixteen studies met the inclusion criteria, which were pooled in an overall all-cause mortality estimate, and five in a
cardiovascular mortality estimate. After adjustment for demographic variables and micro- and macrovascular complications,
depression was associated with an increased risk of all-cause mortality (HR = 1.46, 95% CI = 1.29–1.66), and cardiovascular
mortality (HR = 1.39, 95% CI = 1.11–1.73). Heterogeneity across studies was high for all-cause mortality and relatively low for
cardiovascular mortality, with an I-squared of respectively 78.6% and 39.6%. Subgroup analyses showed that the association
between depression and mortality not significantly change when excluding three articles presenting odds ratios, yet this
decreased heterogeneity substantially (HR = 1.49, 95% CI = 1.39–1.61, I-squared = 15.1%). A comparison between type 1 and
type 2 diabetes could not be undertaken, as only one study reported on type 1 diabetes specifically.
Conclusions: Depression is associated with an almost 1.5-fold increased risk of mortality in people with diabetes. Research
should focus on both cardiovascular and non-cardiovascular causes of death associated with depression, and determine the
underlying behavioral and physiological mechanisms that may explain this association.
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Introduction
Depression is common in people with diabetes, affecting
approximately 20% of the patients [1,2]. Two meta-analyses
revealed that people with type 2 diabetes mellitus are 15–24%
more likely to develop depression compared to people without
diabetes [3,4]. Furthermore, individuals with previously diagnosed
diabetes have an increased risk of depression relative to those with
impaired glucose metabolism or undiagnosed diabetes [5].
Depressed individuals with diabetes report lower quality of life
[6] have higher HbA1c levels, indicating suboptimal glycemic
control [7] and are characterized by poor self-care behavior that
may contribute to suboptimal glycemic control [8]. They
demonstrate lower levels of physical activity [9], have more
negative appraisals of insulin therapy [10], are likely to be less
adherent to the prescribed treatment regimen and have less
healthy eating behaviors [8].
Several longitudinal epidemiological studies concluded that the
combination of diabetes mellitus and depression is associated with
higher mortality rates [11,12,13]. For example, Black et al. [11]
demonstrated that people with comorbid depression and diabetes
have a higher risk of developing diabetes-related complications
and also mortality, than those with depression or diabetes alone or
without either condition.
Lin and colleagues [14] showed that people with type 2 diabetes
and comorbid depression had a 36% increased risk of developing
microvascular complications such as end-stage renal disease, low
vision or blindness, retinopathy, foot ulcers or amputations,
compared to individuals with diabetes without depression.
Furthermore, a 25% higher risk of developing macrovascular
complications, such as myocardial infarction or stroke, was
established.
However, the research question whether depression in diabetes
is associated with an increased mortality risk has not been the
subject of a systematic review and meta-analysis. Therefore, the
objective of the present paper was to examine whether depression
increases the risk for all-cause and cardiovascular mortality in
people with diabetes, both by (a) reviewing the literature in a
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systematic way and (b) carrying out a meta-analysis of longitudinal
studies on this subject.
Methods
Search Strategy
Literature searches were conducted through August 16, 2012
using the electronic databases PUBMED and PSYCINFO. The
following search terms were applied: ‘‘diabetes’’ (title/abstract) or
the medical subject headings (MeSH) ‘‘Diabetes Mellitus’’, in
combination with ‘‘depression’’ (title/abstract) or ‘‘depressive
disorder’’ (title/abstract) or ‘‘depressive’’ (title/abstract) or the
MeSH terms ‘‘Depression’’ or ‘‘Depressive disorder’’, combined
with ‘‘mortality’’ (title/abstract) or ‘‘death’’ (title/abstract) or the
MeSH terms ‘‘Mortality’’ or ‘‘Death’’ or ‘‘Diabetes Complica-
tions/mortality’’, combined with ‘‘cohort study’’ (title/abstract) or
‘‘longitudinal’’ (title/abstract) or ‘‘prospective’’ (title/abstract) or
‘‘cohort’’ (title/abstract) or the MeSH term ‘‘Cohort Studies’’. No
restrictions were used. Additionally, reference lists of included
articles were screened by the first author (FvD) to detect
complementary articles which met the selection criteria.
Study Selection
Two authors (FvD, GN) independently evaluated the articles for
eligibility. Studies that met the following criteria were included: 1)
the study design was longitudinal, including both retrospective as
prospective studies, 2) the study population included people
diagnosed with diabetes (clinical or self-report) either as total
sample or subgroup, 3) the outcome variable was mortality, 4) the
association between baseline depression (yes/no, clinical diagnosis
or self-report) and mortality during follow up was analysed.
Studies presenting clinical trials meeting these inclusion criteria
were not included in the meta-analysis, considering these studies
describe the effect of a treatment in people with diabetes and
depression on mortality and not the effect of depression on
mortality in people with diabetes.
All discrepancies were resolved after rechecking the source
papers and further discussion among both authors, and consul-
tation of a third co-author (FP) where needed, with full consensus
before inclusion. Regarding multiple reports on the same dataset,
only one report was included in the meta-analysis, based upon
population size (largest sample size), aim of the article (with
mortality as the main end point) and primary analysis (as
compared to secondary analysis). Three corresponding authors
were contacted for additional information, but we did not receive
further information. No restriction on type of language was placed.
Figure 1 depicts the process of article selection by means of a flow
diagram.
Endpoint
The endpoint was all-cause mortality and, where available,
cardiovascular mortality.
Data Extraction and Statistical Analysis
The results of the data extraction were summarized in a
systematic manner including the following information: first
author name, publication year, country of study, length of
follow-up, study design and sample size (mean age, % female,
type of diabetes), number of depression cases, assessment method
of diabetes/depression/mortality (Table 1), hazard ratios (HRs)
with corresponding 95% CI and multivariable adjustment
(Table 2).
Data from all studies were pooled using the program
Comprehensive Meta-Analysis version 2 (Biostat, Englewood NJ,
2005). If multiple hazard ratios were presented in a given article,
the estimate that most closely adjusted for demographic variables
and micro- and/or macrovascular complications (e.g. retinopathy,
neuropathy) was selected, to expose the independent effect of
depression.
When appropriate, the meta-analysis will be performed using
the fixed effects or the random effects model: in case of
homogeneity (or low heterogeneity) the fixed effects model will
be used. If heterogeneity is substantial (above 50%) the random
effects model will be used. In two studies [11,15] more than one
measure of depression was used. Black and colleagues [11]
measured depressive symptoms at baseline with the CES-D, and
also used a modified version of the CIDI at two years follow up to
determine whether patients suffered from a depressive disorder.
Depressive symptom-scores were included, as they were measured
at baseline. Sullivan et al. [15] reported minor and major
depression based on the PHQ-9, the dichotomisation of PHQ-
9$10 and the continuous PHQ-9 score. As combining major and
minor depression into one estimate would require an additional
step, the readily available dichotomised PHQ-9 score was used.
For three studies [11,14,16] hazard ratios needed to be
combined in order to obtain the estimate of interest (example of
procedure explained in Figure S1 in Supporting Information S1).
In one paper [16] the hazard ratios for men and women were
separately reported. In the case of Lin et al. [17] we assembled the
hazard ratio for minor and major depression into one depression
hazard ratio. For Black et al. [11], we combined the group with
minimal depression (CES-D = 1–15) and without any depressive
symptoms (CES-D = 0) into one group (CES-D ,16).
Five studies [11,18,19,20,21] used the no diabetes, non-
depressed group as the reference category, while we were
interested in the comparison of the two diabetes groups only
(depressed versus non-depressed). Two of these studies [18,21]
performed post hoc analyses in people with diabetes only,
producing the desired estimate.
For the other three studies, we used the information from the
four group scenario to calculate the HR for the comparison of the
depressed and non-depressed diabetes groups (example of
procedure explained in Figure S2 in Supporting Information S1).
In two papers [13,22] no hazard ratios or odds ratios were
presented, so the odds ratios and confidence intervals for these
studies were calculated based on the number of patients who died
in each group.
Statistical heterogeneity was assessed using the I-squared
statistic, which quantifies the percentage of total variation across
studies due to heterogeneity rather than chance, with values of
50% or more indicating a substantial level of heterogeneity [23].
When study outcomes were heterogeneous based on this statistic,
the potential influence of follow-up length, age, method of
depression assessment, method of diabetes assessment, number
of participants and the percentage of females included were
examined. Differences in effect estimates between the subgroups
were assessed by comparing the pooled effect estimates using chi-
squared analysis, comparing logarithms of these estimates.
Additionally, a sensitivity analysis where each study is removed
one by one was done.
Potential publication bias was assessed with Egger’s test of the
intercept [24]. A funnel plot was constructed by plotting the effect
measure against the inverse of its standard error (see Figure S3 in
Supporting Information S1. An asymmetric plot indicates a likely
publication bias, and p,0.05 is considered representative of
statistically significant publication bias.
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Results
A total of 400 potentially relevant articles were retrieved by the
database searches (Figure 1). From this set, 34 full-text articles
were assessed for eligibility. Of these, 15 articles met our inclusion
criteria and were included in the systematic review. Three of these
articles [13,22,25] used a different measure of effect size (odds
ratio) which cannot be pooled in a meta-analysis with hazard
ratios [26]. However, odds ratios can be converted to risk ratios,
which then can be combined with hazard ratios in a meta-analysis
as forms of relative risks [27].
One additional relevant article that was not indexed for
MEDLINE yet, was included in both the review and meta-
analysis [15]. The characteristics and extracted data of the 16
articles are presented in Table 1, and the hazard ratios with
corresponding 95% confidence intervals and covariates used for
analysis in Table 2.
All-cause Mortality
Sixteen studies were included in the meta-analysis, comprising
109046 individuals with diabetes and including 21443 (19.7%)
with comorbid depression. The follow-up periods of included
studies ranged from 2–10 years, with a mean follow-up of 6 years.
The mean age at baseline ranged from 62 to 76 years, with
exception of the only article focusing on type 1 diabetes, with a
mean age of 39 years at baseline [16]. Twelve analyses (75%)
showed a statistically significant association between depression
and mortality in individuals with diabetes.
The pooled hazard ratio for mortality was significantly
increased in patients with diabetes and depression compared with
those without depression (HR 1.46, 95% CI 1.29–1.66, p,0.0001)
(Figure 2). The I2 value was 78.6%, demonstrating high
heterogeneity in the study results. After conducting subgroup
analyses, there were no significant differences for follow-up length,
age, method of depression assessment, method of diabetes
Figure 1. Flow diagram for selection of studies.
doi:10.1371/journal.pone.0057058.g001
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assessment, number of participants and the percentage of females
included. Only a significant difference was found after excluding
the three articles presenting odds ratios (converted to risk ratios).
The pooled hazard ratio of 13 studies presenting hazard ratios was
1.49, 95% CI 1.39–1.61 (p,0.0001) (in both random as fixed
effects model) and an I-squared statistic of 15.1%.A funnel plot of
the 16 studies (Figure S3 in Supporting Information S1) suggests
evidence of publication bias and Egger’s test confirmed this finding
showing significant asymmetry (p [one-tailed] ,0.05).
Cardiovascular Mortality
Five of the 16 studies, comprising 11375 individuals with
diabetes and including 2619 (23%) with comorbid depression, also
specifically reported on cardiovascular mortality as separate
endpoint. Two examined cardiac mortality, two cardiovascular
disease mortality and one coronary disease mortality. The follow-
up periods ranged from 5–8 years, with a mean follow-up of 6.6
years. The mean age at baseline ranged from 63 to 68 years. Two
out of 5 studies found a significant association between depression
and cardiovascular mortality in people with diabetes [19,21], and
there was a trend in a third study [17]. After pooling the HRs for
cardiovascular mortality, the HR was significant (HR = 1.39, 95%
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NCES-D = Center for Epidemiologic Studies Depression Scale.
NBDI = Beck Depression Inventory.
NDSQ = Depression Screening Questionnaire.
NGHS = General Health Status questionnaire.
NHADS-D = Hospital Anxiety and Depression Scale – depression subscale.
NICD-9/10 (-CM) = International Classification of Diseases 9/10 (-Clinical Modification).
NMHI-5 = Mental Health Inventory 5-items, a subscale of the 36-item Short-Form Health Survey.
NPHQ-9/2 = Patient Health Questionnaire 9 items/2 items.
NScan 2.1 = Schedules for Clinical Assessment in Neuropsychiatry 2.1.
NWHO = World Health Organisation.
N* Minor depression: $1 core symptom (depressed mood or anhedonia) +2–4 depressive symptoms for more than half the time, for $2 last weeks.
N** Major depression: $1 core symptom (depressed mood or anhedonia)+$5 depressive symptoms for more than half the time, for $2 last weeks.
doi:10.1371/journal.pone.0057058.t001
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Discussion
This meta-analysis of 16 longitudinal studies shows a positive
association between depression and subsequent mortality rates in
people with diabetes. Compared to those without depression,
depressed individuals had a 46% increased risk for all-cause
mortality. Although based on only 5 studies, our results also show
a 39% increased risk for cardiovascular mortality associated with
the presence of depression in diabetes.
Previous meta-analyses have also found positive associations
between depression and mortality rates in the general population
(RR = 1.81, 95% CI 1.58–2.07) [28] and in patients with













4.7 1.76 (1.12–2.78) Assignment to one of eight study intervention arms, primary/secondary prevention
status, age, sex, race/ethnicity, BMI, weight, waist circumference, duration of diabetes,
blood pressure, triglycerides, LDL and HDL cholesterol, serum creatinine, HbA1c,
fasting glucose, presence of microvascular complications, blood pressure and lipid
medications, education, smoking, alcohol consumption, living alone
Bot et al.
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Ahola et al.
[16] 2012 *
9 1.53 (1.10–2.13) Age, diabetes duration, diastolic blood pressure, smoking, HbA1c, nephropathy
Scherrer et al. [13]
2011 *** ( = RR)
7 1.04 (0.96–1.13) –
Pan et al. [19]
2011 ** ( = RR)
6 1.53 (1.29–1.82) 1.63 (1.19–2.22) + Age, ethnicity, marital status, family history of diabetes and cancer, parental history of
myocardial infarction, BMI, physical activity, alcohol consumption, smoking,
multivitamin use, estrogen hormone use, aspirin use, hypertension,
hypercholesterolemia, heart disease, stroke, cancer
Pieper et al.
[20] 2011 **












2 1.36 (1.16–1.59) Age, gender, race/ethnicity, Charlson score ( = comorbidity index), prior CVA, prior
CVD, prior CVD procedure, prior amputation
Richardson et al.
[50] 2008
10 1.6 (1.3–1.8) Age, race/ethnicity, marital status, employment status and comorbidity (CHD,
hypertension, stroke and cancer)
Bruce et al.
[51] 2005
7.8 1.21 (0.95–1.55) 1.15 (0.80–1.68) # Age, sex, ethnicity, HbA1c, BMI, diabetes duration, smoking, physical activity, blood




8 1.33 (1.02–1.74) 1.07 (0.67–1.71) $ Age, sex, race/ethnicity, poverty: income ratio, education, marital status, smoking,
physical activity, BMI, aspirin use, comorbid medical conditions at baseline (cancer,
hypertension, heart disease, stroke)
Kuo et al. [25]
2004 *** ( = RR)
2 0.97 (0.75–1.24) Age, sex, marital status, education, hypertension, angina or coronary artery disease,




7 2.08 (1.39–3.12) Age, sex, education, acculturation, marital status
Rosenthal et al.
[22] 1998 *** ( = RR)
3 4.50 (1.52–10.43) -
* = pooled hazard ratio of two groups.
** = hazard ratio with diabetes and no depression as reference category, recalculated from four group scenario (diabetes yes/no x depression yes/no) with no diabetes/
no depression as reference category.
*** = odds ratios converted to risk ratios, which then can be combined with hazard ratios in a meta-analysis as forms of relative risks.
# = cardiac mortality.
+ = cardiovascular disease mortality.
$
= coronary heart disease mortality.
NBMI = Body Mass Index.
NCVA = cerebrovascular accident.
NCVD = cardiovascular disease.
NCHD = coronary heart disease.
NCOPD = chronic obstructive pulmonary disease.
doi:10.1371/journal.pone.0057058.t002
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established heart disease (OR = 2.38, 1.76–3.22 and OR = 2.59,
1.77–3.77 for all-cause and cardiac mortality, respectively) [29].
The triad of depression, diabetes and cardiovascular disease is
closely interrelated. Premature cardiovascular disease is the most
common cause of morbidity and mortality in people with diabetes
[30] and co-morbid depression appears to increase the risk of
developing vascular conditions in this group [11,15,17]. However,
depression is also common in people with established cardiovas-
cular disease [31]. Rather than being a (in)direct causal factor,
depression in diabetes may be secondary to having cardiovascular
complications. It may owe its association with mortality to the
increased risk of new cardiovascular events in people with
established cardiovascular conditions [32]. We took this issue into
account by including the risk estimates that were adjusted for
existing vascular disease, and still found an almost 1.5-fold
increased risk of mortality in depressed people with diabetes.
Further prospective studies are needed to examine whether
depression exerts a negative influence on mortality through the
development of new vascular complications. These studies may
also explore whether people with comorbid diabetes and
depression face increased mortality risks beyond cardiovascular
deaths, as suggested by recent results from the Pathways
Epidemiologic Follow-up Study [17].
There are several potential behavioral or physiological mech-
anisms that could explain the increase of mortality for people with
diabetes and depression. Depression is correlated with a decline in
health-maintenance behaviors (e.g. physical activity, smoking, diet)
in general [33], which is also true for people with diabetes [34]. In
addition, depression is associated with several biological alter-
ations; activation of the hypothalamic-pituitary-adrenal axis and
proinflammatory cytokines, sympathic nervous system dysregula-
tion, decrease in heart rate variability and cardiac fibrillation
threshold, which can contribute to an increased risk of cardiovas-
cular mortality, but also mortality of other causes [35].
In line with previous studies examining post-myocardial
infarction depression [29] or depression in community samples
[28], we did not observe a difference in mortality risk between
studies assessing depression using a self-report questionnaire versus
a clinical psychiatric interview. Only a minority of 30–40% of
people with diabetes with an increased level of depressive
symptoms suffers from clinically relevant depressive disorder
[36,37]. However, both major depression and self-reported
depressive symptoms appear to be chronic/recurrent conditions
in people with diabetes [38,39], and both are associated with the
development of diabetes complications [11]. Furthermore, depres-
sive symptoms have been shown to predict the development of
major depression [40].
The results need to be considered in relation to the study
limitations. One important limitation in carrying out a meta-
analysis is the inevitability to combine data from studies that are
not equally designed. This meta-analysis included studies with
differing study design and characteristics, and the results
demonstrated significant heterogeneity. After conducting sub-
group-analyses on follow-up length, age, method of depression
assessment, method of diabetes assessment, number of participants
and the percentage of females included, heterogeneity remained.
However, after excluding the three articles presenting odds ratios
(converted to risk ratios) the heterogeneity decreased substantially.
This may be due to the fact that odds ratios and hazard ratios are
different risk estimates, even after converting odds to risk ratios
and combining them with relative risks [41].
In addition, the included studies often reported multiple hazard
ratios, each adjusted for different covariates. To reveal the
independent effect of depression on mortality we selected the
hazard ratio that was most closely adjusted for both demographic
and micro- and macrovascular complications. Unfortunately,
these estimates sometimes also include adjustment variables
through which depression may influence mortality rates, e.g.
smoking, physical activity, HbA1c. By correcting for these potential
mediators the hazard ratio can be an underestimation of the real
effect of depression on mortality in people with diabetes. With
respect to type of diabetes of study participants, five articles did not
specify this information. Moreover, only one article reported on
individuals with type 1 diabetes, and two articles reported on a
combined study population of people with both type 1 and type 2
diabetes. Because type 2 diabetes is the most prevalent form of
diabetes, cohort studies with patients with type 1 diabetes are
scarce. Finally, we found an indication for publication bias:
negative or insignificant result are often not submitted for
publication by authors, or rejected by reviewers and editors. This
form of bias generally results in an overestimation of the effect.
Despite these limitations several strengths should also be
acknowledged. First, our meta-analysis comprises both all-cause
and cardiovascular mortality. In addition, the independent effect
of depression on mortality was assessed by adjusting for both
demographic variables and micro- and macrovascular complica-
tions where possible.
It is still unclear whether adequate depression recognition and
subsequent depression treatment can help to decrease mortality
rates. Bogner et al. [42] have conducted the Prevention of Suicide
in Primary Care Elderly: Collaborative Trial (PROSPECT) study
that examined a care-management intervention for older primary
care patients with depression. The study had a median follow-up
of more than 4 year. The authors reported that depressed patients
with diabetes in the intervention category were less likely to have
died during the 5-year follow-up interval than depressed diabetic
patients in usual care after accounting for baseline differences
among patients (adjusted hazard ratio 0.49 [95% CI 0.24–0.98]).
However, the statistical methods used by Bogner et al. [42] were
criticized, as they may have resulted in model overfitting [43,44].
Screening for depression in clinical practice may be a helpful first
step, and should be embedded in collaborative care approaches
[45]. Effective intervention strategies include cognitive behavioral
therapy and treatment with antidepressant medication [46]. Given
the close association of depression with suboptimal self-care
behaviors [34], interventions that target behavioral mechanisms
directly (e.g. coping skills training) may be of value as well.
In conclusion, the results of this meta-analysis suggest that
depression is associated with a 1.5-fold increased risk of all-cause
mortality in people with diabetes. Although based on only five
studies, similar results were found for cardiovascular mortality. In
consideration of the study limitations and strengths, we believe
that a 1.5-fold increased risk of all-cause (and cardiovascular)
mortality in people with diabetes is not an over- or underestima-
tion, but could be an accurate risk estimation.
Future studies are encouraged to explore whether the associ-
ation between depression and mortality is similar for people with
type 1 and type 2 diabetes, and to address the behavioral or
physiological pathways that may explain this association.
Figure 2. Meta-analysis of the association between depression and all-cause and cardiovascular mortality.
doi:10.1371/journal.pone.0057058.g002
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